Caplin Point Laboratories Overview
- Year Founded
-
1990
- Status
-
Public
- Employees
-
5,455
- Stock Symbol
-
524742
- Investments
-
3
- Share Price
-
$21.75
- (As of Friday Closing)
Caplin Point Laboratories General Information
Description
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is into the business of pharmaceuticals - producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas markets. The company's key products include: Tablets and capsules, Liquid orals and syrups, Softgel capsules, Injectables (liquid and lyophilized, pre-filled syringes), Ointments, creams, and gels, Powder for injections, Suppositories and ovules, Pre-mix infusion bags, Inhalers and sprays, Oral rehydration salts (ORS), and Sachets.
Contact Information
Website
www.caplinpoint.netCorporate Office
- 3rd Floor, Ashvich Towers, Number 3
- Developed Plots Industrial Estate, Perungudi
- Chennai, Tamil Nadu 600096
- India
Corporate Office
- 3rd Floor, Ashvich Towers, Number 3
- Developed Plots Industrial Estate, Perungudi
- Chennai, Tamil Nadu 600096
- India
Caplin Point Laboratories Stock Performance
As of 20-Nov-2026, Caplin Point Laboratories’s stock price is $21.75. Its current market cap is $1.65B with 76M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $21.75 | $22.31 | $15.85 - $31.24 | $1.65B | 76M | 14.5K | $0.98 |
Caplin Point Laboratories Financials Summary
As of 30-Sep-2026, Caplin Point Laboratories has a trailing 12-month revenue of $257M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 2,045,501 | 1,098,236 | 1,678,386 | 1,116,613 |
| Revenue | 257,027 | 245,732 | 227,211 | 202,879 |
| EBITDA | 103,486 | 91,677 | 80,385 | 69,018 |
| Net Income | 74,311 | 72,568 | 63,426 | 55,214 |
| Total Assets | 455,479 | 428,762 | 375,367 | 323,541 |
| Total Debt | 481 | 489 | 587 | 236 |
Caplin Point Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Caplin Point Laboratories Comparisons
Industry
Financing
Details
Caplin Point Laboratories Competitors (32)
One of Caplin Point Laboratories’s 32 competitors is J. B. Chemicals & Pharmaceuticals, a Formerly PE-Backed company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| J. B. Chemicals & Pharmaceuticals | Formerly PE-Backed | Mumbai, India | ||||
| Beximco Pharmaceuticals | Corporation | Dhaka, Bangladesh | ||||
| Ciron Drugs And Pharmaceuticals | Corporation | Mumbai, India | ||||
| Macleods Pharmaceuticals | Corporation | Mumbai, India | ||||
| Emcure Pharmaceuticals | Formerly PE-Backed | Pune, India |
Caplin Point Laboratories Signals
Caplin Point Laboratories Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Caplin Point Laboratories Investments & Acquisitions (3)
Caplin Point Laboratories’s most recent deal was a Merger/Acquisition with Triwin Pharma for . The deal was made on 03-Jun-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Triwin Pharma | 03-Jun-2025 | Merger/Acquisition | Pharmaceuticals | ||
| Neoethicals Chile | 01-Apr-2025 | Merger/Acquisition | Distributors/Wholesale | ||
| Hainan Jointown Caplinpoint Pharmaceutical Company | 06-Aug-2018 | Joint Venture | Pharmaceuticals |
Caplin Point Laboratories ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
27.41 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Caplin Point Laboratories FAQs
-
When was Caplin Point Laboratories founded?
Caplin Point Laboratories was founded in 1990.
-
Where is Caplin Point Laboratories headquartered?
Caplin Point Laboratories is headquartered in Chennai, India.
-
What is the size of Caplin Point Laboratories?
Caplin Point Laboratories has 5,455 total employees.
-
What industry is Caplin Point Laboratories in?
Caplin Point Laboratories’s primary industry is Pharmaceuticals.
-
Is Caplin Point Laboratories a private or public company?
Caplin Point Laboratories is a Public company.
-
What is Caplin Point Laboratories’s stock symbol?
The ticker symbol for Caplin Point Laboratories is 524742.
-
What is the current stock price of Caplin Point Laboratories?
As of 20-Nov-2026 the stock price of Caplin Point Laboratories is $21.75.
-
What is the current market cap of Caplin Point Laboratories?
The current market capitalization of Caplin Point Laboratories is $1.65B.
-
What is Caplin Point Laboratories’s current revenue?
The trailing twelve month revenue for Caplin Point Laboratories is $257M.
-
Who are Caplin Point Laboratories’s competitors?
J. B. Chemicals & Pharmaceuticals, Beximco Pharmaceuticals, Ciron Drugs And Pharmaceuticals, Macleods Pharmaceuticals, and Emcure Pharmaceuticals are some of the 32 competitors of Caplin Point Laboratories.
-
What is Caplin Point Laboratories’s annual earnings per share (EPS)?
Caplin Point Laboratories’s EPS for 12 months was $0.98.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process